|Drug name||Epothilone D|
|DrugBank||Primary Accession Number: DB01873|
|Type||Experimental, Investigational, Small Molecule|
|Indication||Investigated for use/treatment in colorectal cancer, lung cancer, breast cancer, solid tumors, and prostate cancer.|
|Mechanism of Action||The principal mechanism of the epothilone class is inhibition of microtubule function. Microtubules are essential to cell division, and epothilones therefore stop cells from properly dividing.|
You need to load/activate the cURL extension (http://www.php.net/cURL).
|Protein Binding||Not available|